X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (664) 664
Book Review (104) 104
Publication (64) 64
Book Chapter (11) 11
Conference Proceeding (4) 4
Government Document (3) 3
Magazine Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (474) 474
humans (454) 454
female (255) 255
oncology (249) 249
male (226) 226
17p deletion (168) 168
middle aged (165) 165
adult (150) 150
17p (142) 142
aged (139) 139
hematology (139) 139
prognosis (123) 123
genetics & heredity (105) 105
mutation (99) 99
chromosomes, human, pair 17 (95) 95
child (91) 91
chromosomes, human, pair 17 - genetics (89) 89
cancer (88) 88
aged, 80 and over (74) 74
chronic lymphocytic leukemia (74) 74
adolescent (73) 73
p53 (73) 73
chromosome deletion (72) 72
in situ hybridization, fluorescence (71) 71
leukemia, lymphocytic, chronic, b-cell - genetics (70) 70
chromosome aberrations (67) 67
mutations (64) 64
cll (63) 63
child, preschool (62) 62
chromosome 17p (62) 62
survival (60) 60
tumor suppressor protein p53 - genetics (54) 54
loss of heterozygosity (51) 51
phenotype (50) 50
expression (48) 48
astronomy & astrophysics (46) 46
open-label (46) 46
comparative genomic hybridization (45) 45
gene (45) 45
clinical neurology (44) 44
genes, p53 (44) 44
karyotyping (44) 44
leukemia (44) 44
deletion (43) 43
genetic aspects (42) 42
primitive neuroectodermal tumors (42) 42
analysis (41) 41
gene deletion (41) 41
heterozygosity (41) 41
medulloblastoma (41) 41
abridged index medicus (40) 40
cytogenetics (40) 40
cell biology (39) 39
central-nervous-system (39) 39
disease progression (39) 39
medulloblastoma - genetics (39) 39
pathology (39) 39
polymerase chain reaction (39) 39
base sequence (38) 38
fludarabine (38) 38
ibrutinib (38) 38
molecular sequence data (38) 38
biochemistry & molecular biology (37) 37
leukemia, lymphocytic, chronic, b-cell - drug therapy (37) 37
research (37) 37
rituximab (36) 36
stem-cell transplantation (36) 36
abnormalities (35) 35
medicine & public health (34) 34
tp53 (34) 34
tumor-suppressor gene (34) 34
chromosome mapping (33) 33
treatment outcome (32) 32
infant (31) 31
risk factors (31) 31
carcinoma (30) 30
therapy (30) 30
tumor proteins (30) 30
chronic lymphocytic-leukemia (29) 29
comets (29) 29
genes (29) 29
chemotherapy (28) 28
comets: individual (28) 28
del (28) 28
in-situ hybridization (28) 28
leukemia, lymphocytic, chronic, b-cell - pathology (28) 28
neurosciences (28) 28
brain neoplasms - genetics (27) 27
care and treatment (27) 27
children (27) 27
chromosome 17 (27) 27
p53 gene (27) 27
progression (27) 27
17p duplication (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
comets: general (26) 26
development and progression (26) 26
diagnosis (26) 26
dna mutational analysis (26) 26
leukemia, lymphocytic, chronic, b-cell - therapy (26) 26
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (652) 652
French (8) 8
Polish (4) 4
German (3) 3
Hungarian (2) 2
Portuguese (2) 2
Russian (2) 2
Spanish (2) 2
Catalan (1) 1
Chinese (1) 1
Czech (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Experimental Cell Research, ISSN 0014-4827, 09/2018, Volume 370, Issue 2, pp. 254 - 263
Chromosome 17p deletions (del(17p)) are present in about 11% of newly diagnosed multiple myeloma (MM) patients and related to inferior prognosis. Bortezomib... 
Long noncoding RNA PRAL | BMP2 | Bortezomib | miR-210 | Multiple myeloma | Chromosome 17p deletions | SURVIVAL | DEL(17P) | REGION | CELL BIOLOGY | 17P DELETIONS | LONG NONCODING RNA | ONCOLOGY | GROWTH | MUTATIONS | CELL | TP53 | MODULATION | Animal experimentation | Bone morphogenetic proteins | Antisense RNA | Prognosis
Journal Article
Astronomy and Astrophysics, ISSN 0004-6361, 11/2010, Volume 522, Issue 7, p. A82
Aims. On October 24, 2007 the comet 17P/Holmes underwent an outburst that was extraordinary in both duration and size. We attempted to determine the cause of... 
Comets: individual: 17P/ Holmes | Comets: general | OXYGEN | COMET 17P/HOLMES | comets: individual: 17P/Holmes | CATALOG | ASTRONOMY & ASTROPHYSICS | EMISSION-LINES | comets: general | SPECTRA | SPECTROGRAPH
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 04/2019, Volume 60, Issue 5, pp. 1312 - 1315
We hypothesized that ofatumumab with sequential methylprednisolone - alemtuzumab would be an effective and tolerable regimen for patients with high-risk... 
deletion 17p | CLL | TP53 | alloHSCT | MRD | ONCOLOGY | COMBINATION | HEMATOLOGY
Journal Article
Oncotarget, ISSN 1949-2553, 06/2019, Volume 10, Issue 40, pp. 4002 - 4003
Journal Article
BLOOD, ISSN 0006-4971, 06/2019, Volume 133, Issue 26, pp. 2765 - 2775
This single-arm, open-label, phase 1b study evaluated the maximum tolerated dose (MTD) of venetoclax when given with obinutuzumab and its safety and... 
17P DELETION | CLL | THERAPY | CYCLOPHOSPHAMIDE | RITUXIMAB | IBRUTINIB | OPEN-LABEL | OUTCOMES | INHIBITOR | HEMATOLOGY | FLUDARABINE | Lymphoid Neoplasia
Journal Article
The Astronomical Journal, ISSN 1538-3881, 10/2009, Volume 138, Issue 4, pp. 1062 - 1071
Numerous sets of narrowband filter photometry were obtained of Comet 17P/Holmes from Lowell Observatory during the interval of 2007 November 1 to 2008 March 5.... 
Comets | Photometric | Individual (17P/Holmes)-techniques
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2018, Volume 36, Issue 19, pp. 1991 - 1993
Journal Article
Astrophysical Journal, ISSN 0004-637X, 02/2016, Volume 818, Issue 1, p. 67
We performed a monitoring observation of a Jupiter-family comet, 17P/Holmes, during its 2014 perihelion passage to investigate its secular change in activity.... 
comets: individual (17P/Holmes) | comets: general | interplanetary medium | 2007 OUTBURST | KUIPER-BELT | MODEL | GRAINS | NUCLEUS | PHOTOMETRY | ASTRONOMY & ASTROPHYSICS | ROSETTA MISSION | DUST MANTLE | 67P/CHURYUMOV-GERASIMENKO | Comets | Dust | Comet nuclei | Perihelions | Mathematical models | Outbursts | Photometry | Monitoring
Journal Article
Journal of Clinical and Diagnostic Research, ISSN 2249-782X, 02/2018, Volume 12, Issue 2, pp. GC01 - GC05
Journal Article
LEUKEMIA, ISSN 0887-6924, 02/2018, Volume 32, Issue 2, pp. 383 - 390
The Dutch-Belgian Cooperative Trial Group for Hematology Oncology Group-65/German-speaking Myeloma Multicenter Group-HD4 (HOVON-65/GMMG-HD4) phase III trial... 
DIAGNOSED MULTIPLE-MYELOMA | INTERGROUPE FRANCOPHONE | STAGING SYSTEM | MAINTENANCE TREATMENT | PLUS DEXAMETHASONE | ONCOLOGY | RANDOMIZED-TRIAL | 2ND PRIMARY MALIGNANCIES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | DEXAMETHASONE COMBINATION | DELETION 17P
Journal Article
New Astronomy, ISSN 1384-1076, 07/2018, Volume 62, pp. 55 - 61
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 169 - 176
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2018, Volume 378, Issue 12, pp. 1107 - 1120
In a trial involving patients with relapsed or refractory chronic lymphocytic leukemia, the BCL2 inhibitor venetoclax in combination with rituximab resulted in... 
SURVIVAL | TRIAL | MEDICINE, GENERAL & INTERNAL | INDEPENDENT PREDICTOR | 17P DELETION | TARGETING BCL2 | PLUS RITUXIMAB | TP53 MUTATION | PROGRESSION-FREE | OPEN-LABEL | MINIMAL RESIDUAL DISEASE | Recurrence | Bendamustine Hydrochloride - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Neoplasm, Residual | Young Adult | Bendamustine Hydrochloride - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - adverse effects | Tumor Lysis Syndrome - etiology | Aged, 80 and over | Adult | Female | Neutropenia - chemically induced | Rituximab - adverse effects | Kaplan-Meier Estimate | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sulfonamides - adverse effects | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Sulfonamides - administration & dosage | Treatment outcome | Chronic lymphocytic leukemia | Diagnosis | Analysis | Chronic lymphatic leukemia | Cell survival | Hematology | Leukemia | Rituximab | Clinical trials | Oncology | Chromosome deletion | Lymphatic leukemia | Patients | Cancer therapies | Chemotherapy | Clonal deletion | Lysis | Response rates | Bone marrow | Chromosomes | Drug dosages | Chromosome 17 | Neutropenia | Index Medicus | Abridged Index Medicus | Life Sciences | Cancer
Journal Article
Journal Article
Revue Francophone des Laboratoires, ISSN 1773-035X, 04/2019, Volume 2019, Issue 511, pp. 50 - 57
Grâce à l’avènement des nouveaux outils de la génomique, il est aujourd’hui devenu évident que le myélome multiple n’est pas une maladie unique mais une... 
myélome multiple | séquençage de nouvelle génération | multiple myeloma | adaptation thérapeutique | next-generation sequencing | therapeutic adaptation | sous-clones | subclones | 17p deletion | délétion 17p
Journal Article
Blood, ISSN 0006-4971, 04/2019, Volume 134, Issue 6, pp. 534 - 547
Targeted therapy is currently revolutionizing the treatment of cancers, but resistance evolves against these therapies and derogates their success. The PI3K-δ... 
17P DELETION | TCL1 | IDELALISIB | INTEGRIN | KINASE | GENE-EXPRESSION | IBRUTINIB | OPEN-LABEL | HEMATOLOGY | FACTOR-I RECEPTOR | CANCER | Index Medicus | Abridged Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.